论文部分内容阅读
目的审核含丹参酮Ⅱa注射液处方,干预不合理处方,保障患者输液治疗安全。方法药师对2015年11月~2016年11月期间含丹参酮Ⅱa注射液的处方在用前进行审核,发现问题处方34张,药师建议医师修改问题处方。结果 34张问题处方存在超剂量、溶媒不合理、配伍禁忌、不合理使用等,经药师干预,34张问题处方全部改正。结论药师专注于审核含丹参酮Ⅱa注射液处方超剂量、溶媒及配伍问题等,有利于纠正不合理处方,保障患者静脉输液用药安全合理。
Objective To review the prescription of tanshinone Ⅱa injection, to intervene in unreasonable prescription and to ensure the safety of infusion therapy in patients. Methods Pharmacists reviewed the prescription of tanshinone Ⅱa injection from November 2015 to November 2016 and found 34 prescriptions and the physician advised the physician to modify the prescription. Results There were over 34 doses of prescriptions, unreasonable solvents, incompatible taboos and irrational use of 34 prescriptions. After pharmacists’ intervention, 34 prescriptions were corrected. Conclusion The pharmacist is mainly focused on the examination of the overdose, solvent and compatibility of prescriptions containing tanshinone Ⅱa injection, which is good for correcting unreasonable prescriptions and ensuring the safe and reasonable use of intravenous fluids.